IL6 and systemic sclerosis: This M1/M2 model oversimplifies the in vivo macrophage heterogeneity of SSc macrophages, which exhibited both an M1- and M2-like phenotype that was characterized by increased HLA-DR and CD206 surface expressions as well as enhanced IL-6 and TGF-β1 secretions [66].